These medical products could become or have been contaminated due to compromise in sterility and can cause serious adverse health consequences and/or death.

New data shows that Propoxyphene and Propoxyphene-containing products can cause serious toxicity to the heart, even when used at therapeutic doses.

Marketed as a natural dietary supplement to enhance male sexual performance and contains undeclared drug that can dangerously lower blood pressure

Syringes may malfunction, break, or become clogged during the process of attempting to connect to some needleless IV access systems.

Unit may fail suddenly, causing inaccurate flow,back flow,over-infusion, and free flow. Pump does not issue an alarm when this occurs and could result in serious injury or death.

Incorrect results could potentially lead to patients being inappropriately treated with Piperacillin/Tazobactam, which could cause serious injury or death.

The recalled pumps have been found to possibly have a problem with the pump door open alarm, which potentially could result in over infusion of medication.

Product marketed as dietary supplement contains undeclared Sulfoaidenafil, which may interact with nitrates found in some prescription drugs and lower blood pressure to dangerous levels.

UPDATED 11/05/2010. Consumers encouraged to return any product in their possession from the October 2010 recall. Originally posted 10/22/2010

Infusers may cease operation and exhibit an audible and visual alarm. Delay or interruption of infusion therapy may result in serious injury or death.

Fragments of the device could fall into the patient’s chest cavity and damage the heart tissue.

Oversulfated chondroitin sulfate (OSCS) contaminant found during sample testing.

Potential to develop adverse reactions in areas where the particles lodge, which could result in serious adverse events, disability, or death.

FDA laboratory analysis found product to contain inconsistent amounts of belladonna, which can cause harm at larger doses.

Prolonged QT or PR intervals reported when Invirase is used with the antiviral medication, Norvir (ritonavir).

New information warns about increased risk of diabetes and certain cardiovascular diseases (heart attack, sudden cardiac death, stroke) in men receiving these medications for the treatment of prostate cancer.

Uncharacteristic musty or moldy odor.

Exposure to syringes with a sterility issue could result in systemic infection, which may lead to serious injury and/or death.

Hardware communication error may lead to serious injury or death.

Consumers advised to avoid OTC chelation products because of the potential for serious harm associated with their use, including dehydration, kidney failure, and death.